---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-022503"
form_type: "8-K"
ticker: "NXGL"
cik: "0001468929"
company_name: "NEXGEL, INC."
filed_at: "2026-05-12T20:30:25+00:00"
generated_at: "2026-05-12T20:39:05.161218+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NEXGEL appoints two Sequence LifeScience leaders to board; Sequence led $5.5M financing

## Summary
- Brian J. Kieser (CEO) and Kevin M. Harris (COO) of Sequence LifeScience appointed to NEXGEL board effective May 6, 2026.
- Sequence led $5.5M convertible note financing ($0.60/ share conversion, $0.80 warrant) to close Celularity acquisition.
- Kieser individually issued $1M convertible note (same terms: $0.60 conversion, $0.80 warrant) on May 11, 2026.
- Kieser is indirect sole owner of Sequence; Harris is COO with no equity in Sequence.

## SEC filing metadata
- accession: 0001493152-26-022503
- form_type: 8-K
- ticker: NXGL
- cik: 0001468929
- company_name: NEXGEL, INC.
- filed_at: 2026-05-12T20:30:25+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468929/000149315226022503/0001493152-26-022503-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468929/000149315226022503/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-022503
- JSON: https://secwatch.observer/filing/0001493152-26-022503.json
- Plain text: https://secwatch.observer/filing/0001493152-26-022503.txt

## Key facts
- Executive change
  Kevin M. Harris was appointed as Director at NEXGEL, INC..
  - Action: appointed
  - Role: Director
  source text: On May 6, 2026, Brian J. Kieser and Kevin M. Harris (collectively, the “ Board Appointees ”) were appointed to the board of directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468929/000149315226022503/0001493152-26-022503-index.htm
- Executive change
  Brian J. Kieser was appointed as Director at NEXGEL, INC..
  - Action: appointed
  - Role: Director
  source text: On May 6, 2026, Brian J. Kieser and Kevin M. Harris (collectively, the “ Board Appointees ”) were appointed to the board of directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468929/000149315226022503/0001493152-26-022503-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.